Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors	Digestive System Diseases, Digestive System Neoplasms, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, breast cancer, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, intestinal disorder, lung disorder, lung neoplasm, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, neoplasm, non-small cell lung carcinoma, pancreas disorder, pancreatic neoplasm, prostate cancer, prostate disorder, rectal disorder, respiratory system disorder, respiratory tract neoplasm, skin disorder	Recruiting	Phase 1 / Phase 2	2026-02-17		NCT07145255

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
MBrace Therapeutics	2

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
NEXT, Dallas	Irving	United States	1
NEXT, Virginia	Fairfax	United States	1
START San Antonio	San Antonio	United States	30
START, Astera	East Brunswick	United States	1
START, Midwest	Grand Rapids	United States	2
START, Mountain Region	West Valley City	United States	1
UCSF Helen Diller Family Comprehensive Cancer Center	San Francisco	United States	22